|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 30 Aug 2024 | Reference Range | Unit |
|---|---|---|---|
| Cholesterol [Mass/volume] in Serum or Plasma | 154.3 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 100.3 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 86.4 | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47.9 | 40 - 60 | mg/dL |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| All lipid values are within normal limits, with a slight decrease in HDL compared to previous results but still within range. Blood counts are generally normal, except for mildly elevated platelet count and markedly increased platelet distribution width, which may indicate reactive thrombocytosis or platelet activation; clinical correlation is advised. No acute abnormalities detected. |